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Bacterial expression constructs 
DNA fragments were amplified by PCR using C. thermophilum and H. sapiens cDNA. SUMO (small 
ubiquitin-like modifier) tagged proteins were cloned into a modified pET28a vector or a modified pET-
MCN vector containing an N-terminal hexahistidine tag followed by a SUMO tag using BamHI and NotI 
restriction sites (42, 43). Hexahistidine tagged proteins were cloned into a modified pET28a vector 
containing a N-terminal hexahistidine tag followed by a PreScission protease cleavage site using NdeI 
and NotI restriction sites (44). GST tagged proteins were cloned into pGEX-6P1 using the BamHI and 
NotI restriction sites. Additionally, DNA coding for Nsp1 (residues 467-674) and Nup57 (residues 77-
319) or Nup57 (residues 146-319) were cloned sequentially into pETDuet1 (Novagen) for expression of 
untagged protein. Nsp1 was cloned into the first multiple cloning site using NcoI and NotI restriction 
sites while Nup57 was cloned into the second multiple cloning site using NdeI and XhoI restriction sites. 
The selected synthetic antibody (sAB) fragments of sAB-158 and sAB-160 were cloned into the pSFV4 
vector (Peter Loppnau, Structural Genomics Consortium, University of Toronto) using the restriction 
sites NcoI and SalI, and subsequently digested using SalI and BsaI and re-ligated to obtain the C-
terminal hexahistidine tag. Mutants were generated by QuikChange mutagenesis and confirmed by 
DNA sequencing. Details of expression constructs are shown in Table S5. 
 
Protein expression and purification 
Proteins were expressed in E. coli BL21-CodonPlus(DE3)-RIL cells (Stratagene) in Luria-Bertani media 
and induced at an OD 600 of 0.8 with 0.5 mM IPTG. For details of the expression times and 
temperatures see Table S5. Seleno-L-methionine (SeMet) labeled proteins were expressed by a 
methionine pathway inhibition protocol, as previously described (45). Cells were harvested by 
centrifugation and re-suspended in a buffer containing 20 mM TRIS (pH 8.0), 500 mM NaCl, 5 mM 2-
mercaptoethanol (β-ME), supplemented with complete EDTA-free protease inhibitor cocktail (Roche). 
For purification, the cell suspensions of all proteins and protein complexes were supplemented with 
1 mg DNase I (Roche) and lysed using a cell disruptor (Avestin). Cell lysates were cleared by 
centrifugation at 30,000 x g for 1 hour. The supernatants were filtered through a 0.45-µm filter 
(Millipore) and purified using standard chromatography methods; for details see Table S6. Proteins 
were concentrated to ~10-20 mg/ml for biochemical interaction experiments, complex reconstitution, 
and crystallization. 
Purification of Nup192•Nic96R2-SOL. Nup192 and GST tagged Nic96R2-SOL were expressed 
individually. After harvesting cells, were re-suspended in 50 mM TRIS (pH 8.0), 500 mM NaCl, 5 mM β-
ME, 10 % (v/v) glycerol supplemented with complete EDTA-free protease inhibitor cocktail (Roche), 
2 µM bovine lung aprotinin (Sigma) and 1 mM phenylmethanesulfonyl fluoride (PMSF; Sigma). Prior to 
lysis, cell suspensions of GST-Nic96R2-SOL and Nup192 were mixed in a 1:2 ratio. Clarified lysate was 
loaded onto a Ni-NTA column equilibrated in a buffer containing 25 mM TRIS (pH 8.0), 500 mM NaCl, 
5 mM β-ME, 20 mM imidazole, and 5 % (v/v) glycerol and eluted with an imidazole gradient. Peak 
fractions were pooled and loaded onto a Glutathione Sepharose 4 Fast Flow (GE Healthcare) column 
and eluted using a glutathione gradient. Peak fractions were pooled and dialyzed overnight against a 
buffer containing 20 mM TRIS (pH 8.0), 150 mM NaCl, 5 mM DTT, and 5 % (v/v) glycerol in the 
presence of PreScission protease. The protein was concentrated and further purified over a HiLoad 
Superdex 200 16/60 PG column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 150 mM 
NaCl, and 5 mM DTT. Peak fractions were pooled and concentrated to ~20 mg/ml for biochemical 
interaction experiments. 
Purification of CNT•Nic96. Cells containing CNT and Nic96 were grown individually and re-
suspended in 50 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM β-ME, 10 % (v/v) glycerol supplemented with 
complete EDTA-free protease inhibitor cocktail (Roche), 2 µM bovine lung aprotinin (Sigma) and 1 mM 
phenylmethanesulfonyl fluoride (PMSF; Sigma). Prior to lysis, cell suspension containing CNT and 
Nic96 were mixed in a 3:1 ratio. Clarified lysate was loaded onto a Ni-NTA column equilibrated in a 
buffer containing 25 mM TRIS (pH 8.0), 500 mM NaCl, 5 mM β-ME, 20 mM imidazole, and 5 % (v/v) 
glycerol and eluted with an imidazole gradient. Peak fractions were pooled and desalted using a HiPrep 
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 26/20 Desalting (GE Healthcare) column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 
150 mM NaCl, 5 mM DTT, and 5 % (v/v) glycerol in the presence of ULP1 protease. After SUMO 
cleavage, the protein was loaded onto a MonoQ 5/50 GL (GE Healthcare) column equilibrated in 
20 mM TRIS (pH 8.0), 150 mM NaCl, 5 mM DTT, and 5 % (v/v) glycerol and eluted with a sodium 
chloride gradient. Protein-containing fractions were pooled and concentrated to ~5 mg/ml for 
biochemical interaction experiments. 
Purification of sABs. The expression of sABs was induced at an OD 600 of 0.9 with 0.25 mM 
IPTG and grown at 37 °C for 3 hours. The lysate was incubated at 65 °C for 30 minutes and then 
cooled on ice for 15 minutes before centrifugation at 30,000 x g for 1 hour. The supernatant was filtered 
through a 0.45-µm filter (Millipore) and loaded onto a Ni-NTA column equilibrated in 20 mM TRIS 
(pH 8.0), 500 mM NaCl, and 20 mM imidazole. Protein was eluted with a linear gradient of 20 mM TRIS 
(pH 8.0), 500 mM NaCl, and 500 mM imidazole. Protein-containing fractions from the Ni-NTA affinity 
purification were pooled and loaded onto a 5 ml HiTrap MabSelect SuRe (GE Healthcare) column 
equilibrated in a buffer containing 20 mM TRIS (pH 8.0) and 500 mM NaCl and eluted using a linear 
gradient of an elution buffer containing 0.1 M acetic acid. The eluted fractions were dialyzed against a 
buffer containing 20 mM TRIS (pH 8.0) and 100 mM NaCl and concentrated to ~50 mg/ml for 
biochemical interaction experiments, complex reconstitution, and crystallization. 
Purification of CNT•Nic96R1. Purified CNT was mixed with 2-fold molar excess of purified 
SUMO-Nic96R1 and incubated on ice for 30 minutes. The mixture was then loaded onto a HiLoad 
Superdex 200 16/60 PG column equilibrated in buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 
and 5 mM DTT. To obtain untagged CNT•SUMO-Nic96R1, the proteins were mixed in the presence of 
ULP1 protease. Fractions containing either CNT•SUMO-Nic96R1 or untagged CNT•Nic96R1 were pooled 
and concentrated to ~30 mg/ml for biochemical studies. 
Purification of CNT•Nic96R1•sAB-158. Purified CNT was mixed with 2-fold molar excess of 
purified SUMO-Nic96R1, 2-fold molar excess of purified sAB-158, and ULP1 protease, followed by 
incubation on ice for 30 minutes. The mixture was then loaded onto a Superdex 200 10/300 GL column 
equilibrated in buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. Fractions 
containing CNT•Nic96R1•sAB-158 were pooled and concentrated to ~50 mg/ml for biochemical studies 
and crystallization. 
Purification of Nup82NTD•Nup159T•Nup145NAPD. Purified Nup82NTD•Nup159T was mixed with a 
1.2-fold molar excess of Nup145NAPD and incubated on ice for 30 minutes. The mixture was then 
loaded onto a Superdex 200 16/60 PG column equilibrated in buffer containing 20 mM TRIS (pH 8.0), 
100 mM NaCl, and 5 mM DTT. Peak fractions containing a stoichiometric 
Nup82NTD•Nup159T•Nup145NAPD hetero-trimer were pooled and concentrated to ~30 mg/ml for 
biochemical studies and crystallization. 
Reconstitution of hsNup49CCS2+3*•hsNup57CCS3* complexes. Purified hsNup49CCS2+3* was mixed 
with an equimolar amount of hsNup57CCS3* and incubated on ice for 30 minutes. The mixture was then 
loaded onto a HiLoad Superdex 200 16/60 PG column equilibrated in buffer containing 20 mM TRIS 
(pH	  8.0), 100 mM NaCl, and 5 mM DTT. Peak fractions containing a stoichiometric 
hsNup49CCS2+3*•hsNup57CCS3* complex were pooled and concentrated to ~20 mg/ml for crystallization. 
Reconstitution of CNT•Nic96•Nup192•Nup53. The hetero-nonameric IRC protomer including the 
CFC proteins Nup82NTD and Nup159T was reconstituted as follows. A Nup192•Nup53 complex was 
formed by mixing purified Nup192 and Nup53 with a 1.2 fold molar excess of Nup53, incubated on ice 
for 30 minutes and purified over a HiLoad Superdex 200 16/60 PG column equilibrated in a buffer 
containing 20 mM TRIS (pH 8.0), 100 mM NaCl and 5 mM DTT. The Nup192•Nup53 dimer was 
subsequently mixed with a 1.2-fold molar excess of CNT•Nic96, incubated for 30 minutes on ice and 
further purified over a HiLoad Superdex 200 16/60 PG gel filtration column equilibrated in 20 mM TRIS 
(pH 8.0), 100 mM NaCl and 5 mM DTT. Complex-containing fractions were pooled and concentrated to 
~8 mg/ml for biochemical studies. 
Reconstitution of CNT•Nic96•Nup192•Nup53•Nup145N•Nup82NTD•Nup159T. To reconstitute 
CNT•Nic96•Nup192•Nup53•Nup145N•Nup82•Nup159, 1 mg of purified CNT•Nic96•Nup192•Nup53 was 
mixed with 0.8 mg of purified Nup82NTD•Nup159T•Nup145N, incubated for 30 minutes on ice, and 
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 purified over a Superose 6 10/300 GL column equilibrated in 20 mM TRIS (pH 8.0), 100 mM NaCl and 
5 mM DTT. 
 
Generation of synthetic antibodies and monobodies 
The selection of synthetic binders was performed using avi-tagged CNT, CNT•Nic96R1, and 
CNT•Nic96139-201, containing Nup49 with an N-terminal avi-tag. Biotinylation was carried out using 
40 µM protein in a buffer containing 50 mM BICINE (pH 8.3), 100 mM biotin, 10 mM ATP, 10 mM 
magnesium acetate, and 30 µg biotin ligase (BirA) at 30 °C for 2 hours in a total volume of 2 ml. After 
labeling, protein was buffer exchanged using a 5 ml HiTrap Desalting (GE Healthcare) column 
equilibrated with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT and purified 
again using a HiLoad Superdex 200 16/60 PG column equilibrated in the same buffer. The extent of 
biotinylation and efficiency of capture were tested by incubating 10 µg protein with 50 µl of Streptavidin 
MagneSphere Paramagnetic Particles (Promega), followed by a single washing step with 50 µl buffer, 
containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT, and resolving the bound proteins by 
SDS-PAGE and visualizing by Coomassie Brilliant Blue staining. 
For sAB identification, four rounds of competitive selection were performed using 100 nM 
(round 1), 50 nM (round 2), 10 nM (round 3), and 10 nM (round 4) biotinylated CNT, CNT•Nic96R1, or 
CNT•Nic96139-201 and a phage display library according to previously published protocols (46, 47). After 
successful selection, the specificity of candidate sABs was tested against the biotinylated CNT, 
CNT•Nic96R1, and CNT•Nic96139-201 using a single point competitive ELISA assay (46). Only sequence-
unique sABs with the desired binding properties were chosen for further biochemical characterization. 
Monobody libraries were screened with a similar protocol and affinities determined by yeast display, as 
previously described (48, 49). 
To evaluate the binding affinity and specificity of the selected sABs and MBs, 1.5-fold molar 
excess of sAB or MB was incubated with CNT, CNT•Nic96R1, or CNT•Nic96139-201 and loaded onto a 
MonoQ 5/50 GL column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 
5 mM DTT and eluted using a NaCl gradient. Interacting sABs or MBs eluted with the CNT, 
CNT•Nic96R1, or CNT•Nic96139-201, whereas non-interacting sABs or MBs eluted prior to the gradient 
step. The screened sABs or MBs formed stable complexes with CNT, CNT•Nic96R1, and CNT•Nic96139-
201, but failed to differentiate between them. 
 
Multi-angle light scattering coupled to analytical size-exclusion chromatography 
Purified proteins and complex formation were characterized by inline multi-angle light scattering 
following separation on Superdex 200 10/300 GL or Superose 6 10/300 GL columns (50). All proteins 
and complexes were analyzed in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl and 5 mM 
DTT, except those involving Nup192TAIL, which were carried out in a buffer containing 20 mM TRIS 
(pH 8.0), 200 mM NaCl and 5 mM DTT. The chromatography system was connected in series with an 
18-angle light scattering detector (DAWN HELEOS II, Wyatt Technology), a dynamic light scattering 
detector (DynaPro Nanostar, Wyatt Technology), and a refractive index detector (Optilab t-rEX, Wyatt 
Technology). Data were collected every 1 second at a flow rate of 0.5 ml/min at 25 ºC and analyzed 
using ASTRA 6 software, yielding molar mass and mass distribution (polydispersity) of the samples. 
For interaction studies, proteins were mixed and incubated on ice for 30 minutes prior to being applied 
to the gel filtration column. Protein containing fractions were analyzed by SDS-PAGE followed by 
Coomassie brilliant blue staining. 
 
Thermal stability assay 
Purified CNT (10 µg) was incubated in a total volume of 50 µl for 30 minutes at 40-61 ºC, increased in 
3.5 ºC increments. Soluble and pellet fractions were separated by centrifugation at 30,000 x g for 
35 minutes at 4 ºC, resolved by SDS-PAGE, and visualized by Coomassie brilliant blue staining. 
 
GST pull-down protein-protein interaction analysis 
Bait protein (5 µg, purified GST-Nic96R1 or GST) was incubated for 30 minutes with an equimolar 
amount of target proteins in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 4 mM DTT. The 
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 mixtures were then incubated for 30 minutes with 20 µl pre-washed Glutathione Sepharose 4B resin 
(GE Healthcare). The beads were collected by centrifugation at 500 x g for 2 minutes and washed five 
times with 200 µl binding buffer. Bound proteins were released from the resin by addition of 0.5 µg 
PreScission protease and incubation for 20 minutes at room temperature. Samples from the load, 
PreScission eluted supernatant, and post-elution beads were analyzed by SDS-PAGE and visualized 
by Coomassie brilliant blue staining. Because Nup49 and Nup57 were poorly behaved when expressed 
individually, they were not tested in isolation. 
 
Yeast strains, media and miscellaneous genetic methods 
Preparation of all media (yeast peptone dextrose, YPD; synthetic dextrose complete, SDC), LiAc-
mediated yeast transformation and genetic manipulation was carried out according to standard 
protocols. For details of the yeast expression constructs and haploid S. cerevisiae strains see 
Tables S7 and S8. To generate the listed shuffle strains the respective essential genes were replaced 
with either the HIS3 or the natNT2 cassette by homologous recombination, as previously described (51, 
52). Due to the lethality of the deletions, the indicated parental strain was complemented with a 
pRS416 construct carrying the respective full-length S. cerevisiae gene with an N-terminal mCherry tag 
under the control of the PNOP1 promoter prior to chromosomal integration. Subsequently, pRS415-eGFP 
or pRS415-mCherry constructs carrying the various Nup variants were introduced. The transformants 
were selected twice on SDC-leucine (Leu) plates followed by plating twice on SDC+5-fluoroorotic acid 
(5-FOA) to ensure the loss of the pRS416-mCherry construct prior to analysis. The NUP192 shuffle 
constructs and the nup49-313 mutant (EVPIP) were described previously (8, 37). 
 
Yeast cell growth analyses and fluorescence microscopic assays 
For viability and growth analysis, S. cerevisiae strains carrying eGFP-tagged variants of the respective 
scNUP were grown at 30 °C. Ten-fold dilution series were generated, of which 20 µl were spotted on 
SDC-Leu and SDC+5-FOA plates and grown at 23 °C for 5 days. For growth analysis of the shuffled 
strains, 7.5 µl of the dilution series were spotted on YPD plates and grown at 23 °C, 30 °C, and 37 °C 
for 2-4 days. For scNup57 co-localization analysis, cells with a genomic, C-terminal GFP-tagged 
scNUP57 and pRS415-mCherry constructs carrying the various NUP variants in the respective 
knockout background were grown at 30 °C to mid log phase and afterwards shifted for 6 hours to 
37 °C. The large ribosomal subunit scRpl25 reporter assay was performed as described previously 
(53). The pRS411 (for scNUP192 and scNIC96 mutant analysis) or the pRS413 (for scNUP49 mutant 
analysis) vectors carrying mCherry-tagged scRPL25 were co-transformed with the respective pRS415-
eGFP variant plasmids (see above) into the indicated shuffle strain. The transformants were selected 
twice on SDC-LEU-MET or SDC-LEU-HIS plates followed by plating twice on SDC-MET+5-FOA or 
SDC-HIS+5-FOA to ensure the loss of the pRS416-mCherry construct. For analysis, cells were grown 
in selective SDC-MET or SDC-HIS medium at 30 °C to mid-log phase. For fluorescence microscopy, 
live cells were washed once with water, re-suspended and analyzed using a Carl Zeiss Observer Z.1 
equipped with a Hamamatsu camera C10600 Orca-R2. The statistical analysis was carried out using 
three sets of independent images with at least 500 cells each for every analyzed sample. Error bars 
represent standard deviation. 
 
FISH mRNA Export Assay 
Liquid cultures of deletion yeast strains were grown at 30 °C (23 °C for the nic96Δ/Nup57-GFP strain) 
in YPD media to an OD 600 of 0.4 and subsequently shifted to 37 °C for 4 hours prior to fixation in 
formaldehyde. These cells were then analyzed by FISH using an Alexa647-labeled 50-mer oligo(dT) 
probe as previously described (54, 55). The statistical analysis was carried out using three sets of 
independent images with at least 500 cells each for every analyzed sample. Error bars represent 
standard deviation. 
 
Crystallization and structure determination 
Crystals of Nup192TAIL, Nup188TAIL, hsNup49CCS3*, hsNup57CCS3*, Nup57CCS3*, 
hsNup49CCS2+3*•hsNup57CCS3* with 2:4 and 2:2 stoichiometry, Nup82NTD•Nup159T•Nup145NAPD, and 
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 CNT•Nic96R1•sAB-158 were grown at 21 °C in hanging drops containing 1 µl of protein and 1 µl of a 
reservoir solution. SeMet-labeled crystals were grown under similar conditions. For CNT•Nic96R1•sAB-
158, native crystals were derivatized with p-chloromercuribenzoic acid (PCMB), ethyl mercury 
thiosalicylate (EMTS), potassium hexachloroosmate (K2OsCl6), and potassium osmate (K2OsO4). 
Crystals were cryoprotected by supplementing the drop with cryo protectant and flash-frozen in liquid 
nitrogen. For details of the crystallization and cryo protection see Table S9. X-ray diffraction data were 
collected at 100 K at beamline 8.2.2 at the Advanced Light Source (ALS), Lawrence Berkley National 
Laboratory (LBNL), beamline BL12-2 at the Stanford Synchrotron Radiation Source (SSRL), and 
beamline GM/CA-CAT 23ID-D at the Advanced Photon Source (APS). The X-ray diffraction data were 
processed using the HKL2000 and XDS (56, 57). 
Initial phases for all structures were calculated in PHASER using single anomalous dispersion 
(SAD) X-ray diffraction data obtained from SeMet derivatives (58). Solvent flattening and NCS 
averaging were performed in RESOLVE, yielding improved phases and experimental maps of excellent 
quality. In the case of CNT•Nic96R1•sAB-158, the best experimental map was obtained using SAD X-
ray diffraction data obtained from the K2OsCl6 derivative and inclusion of the data in the highest 
resolution shell was beneficial for its quality. Iterative rounds of model building and refinement were 
performed with COOT and PHENIX (59, 60). In the cases of Nup188TAIL and hsNup49CCS2+3*, the 
refinements did not converge in higher symmetry space groups and were therefore carried out in P1. 
The unambiguous assignment of the CNT•Nic96R1•sAB-158 sequence register was aided by 
anomalous difference Fourier map calculations using the derivatives. Subsequently, the assigned 
sequence register was verified by methionine mutants yielding 22 additional selenium sites (Nup49: 
I263M, H276M, L31M, A307M, L332M, E438M; Nup57: I82M, H109M, L113M, E127M, I138M, L198M, 
I233M, L253M, V304M; Nsp1: L527M, L548M, A628M; and Nic96R1: L140M, L158M, L161M, L178M). 
In total 78 heavy atom sites were identified in anomalous difference Fourier maps (fig. S29). 
For all structures, the final models possess excellent Rwork and Rfree values and the assessment 
of their stereochemical qualities with MolProbity revealed no Ramachandran outliers (61). For details of 
the data collection and refinement statistics see Tables S2 to S4. 
	  
Illustrations and figures 
Gel filtration profiles and MALS graphs were generated in IGOR (WaveMetrics) and assembled in 
Adobe Illustrator. Sequence alignments were generated using ClustalX (62) and colored with 
ALSCRIPT (63). Electrostatic potentials were calculated with APBS (Adaptive Poisson-Blotzmann 
Solver) software (64). Structure figures were generated with PyMOL (www.pymol.org). 
 
Coordinates and Structure Factors 
The coordinates and structure factors have been deposited with the Protein Data Bank with accession 
codes 5CWV (Nup192TAIL), 5CWU (Nup188TAIL), 4JQ5 (hsNup49CCS2+3*), 4JNV and 4JNU 
(hsNup57CCS3*), 5CWT (Nup57CCS3*), 4JO7 (hsNup49CCS2+3*•hsNup57CCS3*, 2:2 stoichiometry), 4JO9 
(hsNup49CCS2+3*•hsNup57CCS3*, 2:4 stoichiometry), 5CWW (Nup82NTD•Nup159T•Nup145NAPD) and 
5CWS (CNT•Nic96R1•sAB-158). 
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 Fig. S1. 
Reconstitution and dissection of the IRC. (A to H) SEC-MALS and SDS-PAGE analysis 
corresponding to Figure 1. SEC-MALS profiles of nucleoporins or nup complexes are shown 
individually (red and blue) and after their preincubation (green). Measured molecular masses are 
indicated for the peak fractions. Gray bars indicate fractions that were resolved on SDS-PAGE gels and 
visualized by Coomassie staining. 
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 Fig. S2. 
Reconstitution and dissection of the IRC (continued). (A to F) SEC-MALS and SDS-PAGE analysis 
corresponding to Figure 1. SEC-MALS profiles of nucleoporins or nup complexes are shown 
individually (red and blue) and after their preincubation (green). Measured molecular masses are 
indicated for the peak fractions. Gray bars indicate fractions that were resolved on SDS-PAGE gels and 
visualized by Coomassie staining. 
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 Fig. S3. 
Structure of the minimal CFC in complex with Nup145NAPD. (A) Structure of the 
Nup82NTD•Nup159T•Nup145NAPD hetero-trimer shown in cartoon representation. Nup145NAPD (green), 
Nup159T (red), and Nup82NTD (blue), the Nup82NTD helical 4CD (grey) and 6CD (orange) insertions and 
FGL loop (yellow), and the conserved Nup145NAPD K loop (purple) are illustrated. (B) Structure of the 
previously determined scNup82NTD•scNup159T•mmNup145NAPD hetero-trimer (PDB ID: 3TKN) shown in 
cartoon representation (29). (C) Superposition of the two hetero-trimers in cartoon representation, 
revealing the evolutionary conservation of their architectures, and differing mainly by an angular 
displacement of Nup145APD. (D) The Inset marks the location of the two close-up views, depicting the 
molecular details of the Nup145NAPD-Nup82NTD interaction (top) and the Nup159T-Nup82NTD interaction 
(bottom). The D pocket that binds the K loop is indicated. (E) Sequence alignments of the conserved 
S. cerevisiae and C. thermophilum Nup159T, the Nup82NTD FGL loop, and the Nup145N K/R loop. 
Sequence similarity is shaded from white (less than 60 % similarity), to yellow (60 % similarity), to red 
(100 % identity) using the BLOSUM62 matrix. Numbering below alignment is according to the 
C. thermophilum proteins. Secondary structure is shown above the alignment. 
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 Fig. S4. 
The CNT does not interact with Nic96R2 or Nup192TAIL, nor does Nic96R1 bind Nup192TAIL. (A to C) 
SEC-MALS profiles of nucleoporins or nup complexes are shown individually (red and blue) and after 
their preincubation (green). Measured molecular masses are indicated for the peak fractions. Gray bars 
indicate fractions that were resolved on SDS-PAGE gels and visualized by Coomassie staining. 
Asterisks indicate degradation products or contamination. 
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 Fig. S5. 
Nup188TAIL forms an alternative complex with the CNT. (A) Reconstitution of SUMO-
Nup188TAIL•SUMO-Nic96R1-R2•CNT. (B) Reconstitution of SUMO-Nup188TAIL•SUMO-Nic96R2. (C, D) 
SEC analysis of Nup192TAIL•SUMO-Nic96R2 and SUMO-Nup188TAIL•SUMO-Nic96R2 carried out in a 1 M 
NaCl buffer. SEC profiles of nucleoporins or nup complexes are shown individually (red and blue) and 
after their preincubation (green). Gray bars indicate fractions that were resolved on SDS-PAGE gels 
and visualized by Coomassie staining. Asterisks indicate degradation products or contamination. 
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 Fig. S6. 
Binding of Nup192 and Nup188 to Nic96 is mutually exclusive. (A) SEC interaction analysis of 
SUMO-Nup188TAIL challenging a preformed Nup192•SUMO-Nic96R2 complex. (B) SEC interaction 
analysis of Nup192 challenging a preformed SUMO-Nup188TAIL•SUMO-Nic96R2 complex. SEC profiles 
of nucleoporins or nup complexes are shown individually (red and blue) and after their preincubation 
(green). Proteins were mixed at equimolar ratios. Gray bars indicate fractions that were resolved on 
SDS-PAGE gels and visualized by Coomassie staining. Asterisks indicate degradation products or 
contamination. 
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 Fig. S7. 
Multispecies sequence alignment of Nup192TAIL. Sequences from six diverse fungal species were 
aligned and colored by sequence similarity according to the BLOSUM62 matrix from white (less than 
40 % similarity), to yellow (40 % similarity), to red (100 % identity). Numbering below alignment is 
relative to C. thermophilum. Secondary structure observed in the Nup192TAIL structure is shown above 
the alignment; α-helices (blue bars) and black lines (unstructured regions). Residues tested for their 
ability to interact with Nic96 in a mutational analysis (Figures 2 and S12) are indicated with dots below 
the alignment and colored according to the measured effect; no effect (green), mild effect (orange), 
abolished binding (red). 
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 Fig. S8. 
Surface properties of Nup192TAIL. Surface representation of Nup192TAIL is shown in three different 
orientations, front, back and side. The degree of rotation around the vertical axis is indicated between 
the respective views. (A) Mutated Nup192TAIL residues are colored according to their effect on SUMO-
Nic96R2 binding; no effect (green), mild effect (orange), abolished binding (red). (B) Surface 
representation colored according to sequence identity based on the alignment in Figure S7. (C) Surface 
representation colored according to electrostatic potential from -10 kBT/e (red) to +10 kBT/e (blue). 
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 Fig. S9. 
Multispecies sequence alignment of Nup188TAIL. Sequences from seven diverse fungal species 
were aligned and colored by sequence similarity according to the BLOSUM62 matrix from white (less 
than 40 % similarity), to yellow (40 % similarity), to red (100 % identity). Numbering below alignment is 
relative to C. thermophilum. Secondary structure observed in the Nup188TAIL structure is shown above 
the alignment; α-helices (blue bars) and black lines (unstructured regions). 
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 Fig. S10. 
Surface properties of Nup188TAIL. Surface representation of Nup188TAIL is shown in three different 
orientations, front, back and side. Rotations around the vertical axis are indicated between the 
respective views. (A) Surface representation colored according to sequence identity based on 
alignment in Figure S9. (B) Surface representation colored according to electrostatic potential 
from -10 kBT/e (red) to +10 kBT/e (blue). 
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 Fig. S11. 
Comparison of ctNup188TAIL and mtNup188TAIL structures. Cartoon representations of (A) 
C. thermophilum Nup188TAIL (red), (B) M. thermophila Nup188TAIL (grey) (PDB ID: 4KF8) (31), and (C) a 
superposition of the two structures is shown in two different orientations. 
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 Fig. S12. 
Identification of Nup192TAIL mutations that disrupt SUMO-Nic96R2 binding. (A) SEC interaction 
analysis between Nup192TAIL mutants and SUMO-Nic96R2. SEC profiles are colored according to the 
effect on SUMO-Nic96R2 binding; no effect (gray), mild effect (orange), or abolished binding (red). As 
reference, the wild type complex is shown (green). A gray bar indicates fractions that were resolved on 
SDS-PAGE gels and visualized by Coomassie staining. (B) Summary of tested Nup192TAIL mutants and 
their effect on SUMO-Nic96R2 binding; (-) no effect, (+) decreased binding, (+++) abolished binding. The 
colors of the dots correspond to the color of the respective SEC profile in (A). 
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 Fig. S13. 
Multispecies sequence alignment of Nic96R1-R2. Sequences from eight diverse species were aligned 
and colored by sequence similarity according to the BLOSUM62 matrix from white (less than 40 % 
similarity), to yellow (40 % similarity), to red (100 % identity). Numbering below alignment is relative to 
C. thermophilum. The secondary structure is shown above the alignment; α-helices are represented by 
blue bars. Black bars above the alignment indicate CNT-binding (R1) and Nup192-binding regions (R2). 
Dots below the alignment indicate the positions of mutations tested for CNT or Nup192TAIL binding 
(Figures 3, S15, and S16); no effect (green), mild effect (orange), abolished binding (red). 
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 Fig. S14. 
Salt stability of the CNT•SUMO-Nic96R1 complex. SEC analysis of purified CNT•SUMO-Nic96R1 
carried out in a buffer containing 0.1 M (yellow), 0.5 M (light orange) or 1.0 M NaCl (red). A gray bar 
indicates fractions that were resolved on a SDS-PAGE gel and visualized by Coomassie staining. 
  
35
36
 Fig. S15. 
Mapping and mutational analysis of the minimal Nic96R1 region required for CNT binding. (A, B) 
Analyzed Nic96R1 truncations and Nic96R1 leucine-alanine mutants are indicated below the primary 
Nic96R1 sequence. SEC-MALS profiles of SUMO-Nic96R1 fragments or mutants preincubated with CNT 
are shown and colored according to their effect on complex formation; mild effect (orange) or abolished 
binding (red). As reference, SEC profiles of CNT (black) and SUMO-Nic96R1 (blue) and their 
preincubation (green) are shown. Measured molecular masses are indicated for the peak fractions. 
Gray bars indicate fractions that were resolved on SDS-PAGE gels and visualized by Coomassie 
staining. LL1, LL2, and LLLL refer to the three combinations of SUMO-Nic96R1 leucine-alanine mutants 
tested. Asterisks indicate degradation products or contamination. 
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 Fig. S16. 
Identification of Nic96R2 mutations that disrupt Nup192TAIL binding. (A) SEC interaction analysis 
between SUMO-Nic96R2 mutants and Nup192TAIL. SEC profiles are colored according to the effect on 
Nup192TAIL binding; no effect (gray), mild effect (orange), or abolished binding (red). For reference, 
SEC profiles of wild type Nup192TAIL•SUMO-Nic96R2 (green) and Nup192TAIL (black) are shown. A gray 
bar indicates fractions that were resolved on SDS-PAGE gels and visualized by Coomassie staining. 
(B) Summary of tested SUMO-Nic96R2 mutants and their effect on Nup192TAIL binding; (-) no effect, (+) 
decreased binding, (+++) abolished binding. The colors of the dots correspond to the color of the 
respective SEC profile in (A). 
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 Fig. S17. 
S. cerevisiae GFP-Nic96 and mCherry-Nic96 constructs used for in vivo analyses. The domain 
architecture of S. cerevisiae Nic96 is shown and colored according to Figure 1. Black lines indicate the 
regions that were removed in various Nic96 deletion mutants. The positions of the F159A and LLLL 
mutants that abolish Nup192 and CNT binding, respectively, are highlighted in yellow. 
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 Fig. S18. 
Characterization of channel nucleoporin fragments and the intact CNT. (A) Domain structures of 
the three CNT-forming channel nups from H. sapiens, R. norvegicus, and C. thermophilum. Bars 
indicate the boundaries of the crystallized Nup57 (blue, orange), Nup49 (yellow), and Nsp1 (green) 
fragments. (B) Crystal structures of seven channel nup fragments in isolation or in complex colored 
according to (A). The species and fragment stoichiometry are indicated for each structure. For clarity, 
only the homo-dimers of H. sapiens and R. norvegicus Nup49CCS2+3* are shown. The structures of 
Nup57CCS3*, hsNup57CCS3* (two different states), hsNup49CCS2+3*, and hsNup49CCS2+3*•hsNup57CCS3* 
(with 1:2 and 2:2 stoichiometry) reported here are indicated with blue dots. The previously determined 
structure of rnNup57CCS1*•rnNsp1CCS1* (1:2 stoichiometry), rnNup57CCS3*, rnNup49CCS2+3*, and 
rnNup49CCS2+3*•rnNup57CCS3* (with 1:2 stoichiometry) are marked with red dots (22, 25, 26). (C) SEC-
MALS profiles of the CNT at three different concentrations (yellow to red). Asterisks indicate that the 
crystallized channel nup fragments do not exactly correspond to the predicted coiled-coil regions. (D) 
SEC-MALS interaction analysis of CNT (red), SUMO-Nic96R1 (blue), and after their preincubation 
(green). Measured molecular masses are indicated for the peak fractions. Gray bars indicate fractions 
that were resolved on SDS-PAGE gels and visualized by Coomassie staining. (E) GST pull-down 
interaction analysis of Nsp1, Nup49•Nup57 or the premixed CNT with GST-Nic96R1 or GST as bait. The 
input, PreScission protease elution, and post-elution beads were analyzed by SDS-PAGE and 
Coomassie staining. Nic96R1 specifically pulls-down the intact CNT and fails to interact with Nsp1 or 
Nup49•Nup57. 
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 Fig. S19. 
Expression and solubility analysis of H. sapiens channel nups. (A) Domain architecture of the 
three human channel nups Nup49 (yellow), Nup57 (blue/purple), and Nsp1 (green) are shown. (B) The 
expression and solubility levels of individual CNT-fragments expressed as GST-fusions, hexahistidine 
(HIS6) or HIS6-SUMO tagged proteins are indicated; not expressed, insoluble (-) to highly expressed, 
highly soluble (+++). Crystallized fragments are highlighted with a black bar and a black dot. 
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 Fig. S20. 
Expression and solubility analysis of C. thermophilum channel nups. (A) Domain architecture of 
the three C. thermophilum channel nups are shown and colored according to Figure S19. (B) The 
expression and solubility levels of individual CNT-fragments expressed as GST-fusions, hexahistidine 
(HIS6) or HIS6-SUMO tagged tagged proteins are indicated; not expressed, insoluble (-) to highly 
expressed, highly soluble (+++). Crystallized fragments are highlighted with a black bar and a black dot. 
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 Fig. S21. 
Expression and solubility analysis of S. cerevisiae channel nups. (A) Domain architecture of the 
three S. cerevisiae channel nups are shown and colored according to Figure S19. (B) The expression 
and solubility levels of individual CNT-fragments expressed as GST-fusions, hexahistidine (HIS6) or 
HIS6-SUMO tagged proteins are indicated; not expressed, insoluble (-) to highly expressed, highly 
soluble (+++). Crystallized fragments are highlighted with a black bar and a black dot. 
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 Fig. S22. 
Biochemical and structural analysis of different hsNup49CCS2+3* and hsNup57CCS3* complexes 
reveal different oligomerization states. (A) Domain architecture of hsNup49 and hsNup57 is shown 
and colored according to Figure S19. (B) SEC-MALS profiles of hsNup49CCS2+3* are shown at 
increasing protein concentrations (yellow to red). (C) SEC-MALS profiles of hsNup57CCS3* and 
hsNup49CCS2+3* are shown individually (blue and yellow) and after their preincubation (green). 
Measured molecular masses are indicated for the peak fractions. Gray bars indicate fractions that were 
resolved on SDS-PAGE gels and visualized by Coomassie staining. Colored bars indicate the fractions 
that were pooled for crystallization. (D) Crystallization drop showing two different crystal forms of the 
hsNup57CCS3*•hsNup49CCS2+3* complex with 1:2 (purple) and 2:2 (magenta) stoichiometry. (E) The 
structure of the three different homo-oligomers of hsNup49CCS2+3* (elongated homo-tetramer, compact 
homo-tetramer, and homo-dimer), the homo-tetramer of hsNup57CCS3*, and the 
hsNup57CCS3*•hsNup49CCS2+3* complexes with 2:1 and 2:2 stoichiometry are shown from left to right. 
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 Fig. S23. 
Biochemical and structural analysis of the Nup57CCS3* segment from different species. (A) 
Domain architectures of the C. thermophilum, H. sapiens, and R. norvegicus Nup57 are shown and 
colored according to Figure S19. SEC-MALS profiles of (B) Nup57CCS3* and (C) hsNup57CCS3*. 
Measured molecular masses are indicated for the peak fractions. Gray bars indicate fractions that were 
resolved on SDS-PAGE gels and visualized by Coomassie staining. (D) Structures of human and 
C. thermophilum Nup57CCS3* shown in cartoon representation, shown in the same orientations as the 
previously determined rat Nup57CCS3* (25). Two different states of hsNup57CCS3* were obtained in 
different crystal packing arrangements. (E) Structural comparison of the R. norvegicus and 
C. thermophilum Nup57CCS3* homo-tetramers. The Nup57CCS3* and hsNup57CCS3* homo-tetramers 
possess different helical packing arrangements and fail to superpose. As a reference, two 
corresponding residues Q473 (red) and Y293 of the C. thermophilum and R. norvegicus homo-
tetramers, respectively, are indicated, illustrating their distinct helical packing. Notably, the 
C. thermophilum Nup57CCS3* is homo-dimeric in solution, whereas the human homologue forms a 
homo-tetramer. 
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 Fig. S24. 
Structure of hsNup49•Nup57 with 2:2 stoichiometry. Cartoon representation of the 
hsNup57CCS3*•hsNup49CCS2+3* hetero-dimer with 2:2 stoichiometry. Two orientations are shown from the 
front and side; hsNup57CCS3* (blue) and hsNup49CCS2+3* (yellow). A surface representation of the two 
views is shown on the right. 
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 Fig. S25. 
Analysis of oligomeric state of human channel nup fragment mixtures. (A) Domain architectures 
of the H. sapiens Nup49 and Nup57 are shown and colored according to Figure S19. (B) SEC-MALS 
profiles of hsNup57CCS3* preincubated with increasing molar amounts of hsNup49 CCS2+3* (red, green, 
and blue). (C) SEC-MALS profiles of hsNup49CCS2+3* preincubated with increasing molar amounts of 
hsNup57CCS3* (yellow, red, green, and blue). Measured molecular masses are indicated for the peak 
fractions. Gray bars indicate fractions that were resolved on SDS-PAGE gels and visualized by 
Coomassie staining. An arrow indicates the position of a higher molecular mass peak, which was 
previously described as a Nup57CCS3*•Nup49CCS2+3* complex with 6:4 stoichiometry, which constitutes 
the keystone for the open ring structure in the “ring model” (26). The abundance of this peak increases 
with increasing amounts of hsNup49CCS2+3*, whereas it stays constant in the presence of increasing 
amounts of hsNup57CCS3*. The corresponding SDS-PAGE analysis shows that Nup49 is substantially 
more abundant in this peak. To rule out that differential staining of the two proteins causes a perceived 
excess of hsNup49CCS2+3*, hsNup49CCS2+3* was mixed with different molar amounts of hsNup57CCS3*, 
analyzed by SDS-PAGE and compared to the protein in the unknown peak (cyan). This analysis 
confirms an abundance of hsNup49CCS2+3* in the peak. 
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 Fig. S26. 
Analysis of hsNup49CCS2+3* mutants that affect the formation of higher oligomeric states. (A) 
Domain architectures of the H. sapiens Nup49 and Nup57 are shown and colored according to 
Figure S19. A red dot indicates the position of the Y420F mutant in hsNup49, which was previously 
suggested to stabilize a hsNup57CCS3*•hsNup49CCS2+3* assembly with 6:4 stochiometry (26). (B) SEC-
MALS profiles of wild type hsNup49CCS2+3* (blue) and hsNup49CCS2+3* Y420F (red) in isolation and (C) 
preincubated with equimolar amounts of hsNup57CCS3* (green and yellow; right). The 
Nup49CCS3* Y420F mutant decreases the height of the ~60 kDa peak (black arrow) in the presence of 
Nup57CCS3*, contrary to a previous report (26). SEC-MALS profiles of (D) hsNup49CCS2+3* Y420F and 
(E) hsNup49CCS2+3* ΔC417 at increasing protein concentrations. As reference, the wild type 
hsNup49CCS2+3* SEC profile at a protein concentration of 18 mg/ml is shown (black). Measured 
molecular masses are indicated for the peak fractions. Gray bars indicate fractions that were resolved 
on SDS-PAGE gels and visualized by Coomassie staining. (F) Close-up view of the elongated hetero-
tetramer interface of hsNup49CCS2+3* in cartoon representation. The C-terminal two helical turns that are 
absent in the hsNup49CCS2+3* ΔC417 mutant are colored in red. The hsNup49CCS2+3* Y420F mutant 
forms higher order homo-oligomers with increasing molecular masses which is abolished in the 
hsNup49CCS2+3* ΔC417 mutant. 
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 Fig. S27. 
Probing the CNT accessibility and assembly state in the IRC with synthetic monobodies. (A) 
Sequence alignment of the variable loops (BC, DE, FG) of 10 monobodies generated against either the 
CNT or the CNT•Nic96R1 complex. White bars indicate gaps in the alignment between loops. Single 
residue similarity is shaded from white (less than 40 % similarity), to yellow (40 % similarity), to red 
(100 % identity) using the BLOSUM62 matrix. (B) The dissociation constant of each monobody for CNT 
binding is shown. (C) The monobody scaffold is shown in cartoon representation highlighting the 
variable DE (blue), BC (yellow) and FG (magenta) loops. (D) A pairwise protein interaction matrix 
indicating competitive (blue) and non-competitive (green) binding to the CNT for the tested monobodies 
as determined by SEC-MALS analysis. (E) The monobodies are grouped according to their competitive 
CNT binding properties, indicating two distinct binding sites. (F) SEC-MALS profiles of CNT•SUMO-
Nic96R1 (blue), CNT•SUMO-Nic96R1 bound to a single monobody (SUMO-MB6; red), and bound to 2 
monobodies (SUMO-MB6 and SUMO-MB9; yellow) are shown. (G) SEC-MALS profiles of 
CNT•Nic96•SUMO-MB6•SUMO-MB9 (blue), Nup192•Nup145N (red), and after their preincubation 
(green) are shown. Measured molecular masses are indicated for the peak fractions. Gray bars indicate 
fractions that were resolved on SDS-PAGE gels and visualized by Coomassie staining. MALS and 
SDS-PAGE confirm the presence of the two monobodies MB6 and MB10 in the peak fractions of the 
IRC, confirming the steric accessibility of the CNT for monobody binding in solution. 
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 Fig. S28. 
Probing the CNT accessibility and assembly state in the IRC with synthetic antibodies. (A) SEC-
MALS profiles of the CNT (blue), the CNT preincubated with sAB-158 (red) and the CNT preincubated 
with sAB-158 and sAB-160 (green) are shown. (B) SEC-MALS profiles of the CNT•sAB-158 (blue), the 
Nup192TAIL•SUMO-Nic96R1-R2 (red) and after their preincubation (green) are shown. (C) SEC-MALS 
profile of Nup192•Nic96•Nup145N•CNT•sAB-158 (blue). Measured molecular masses are indicated for 
the peak fractions. Gray bars indicate fractions that were resolved on SDS-PAGE gels and visualized 
by Coomassie staining. MALS and SDS-PAGE confirm stoichiometric complexes and the presence of 
sAb-158 in the peak fractions of the minimal and intact IRC, indicating the accessibility of the CNT for 
synthetic antibody binding and confirming that the CNT adopts the same assembly state in the IRC as 
observed in the crystal structure. 
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 Fig. S29. 
Experimental phasing of the CNT•Nic96R1•sAB-158 structure. (A) Anomalous difference Fourier 
maps were calculated from X-ray diffraction data collected at the selenium, osmium and mercury peak 
wavelengths. A ribbon representation of the structure of the CNT•Nic96R1•sAB-158 complex with the 
indicated anomalous difference Fourier maps contoured at 3.5 σ is shown. The 29 introduced 
methionine mutants in Nsp1, Nup49, Nup57, and Nic96R1 yielded additional 22 selenium sites, 
validating the sequence register. (B) Experimental electron density map after density modification of the 
CNT•Nic96R1•sAB-158 complex phased with the anomalous signal from crystals soaked with potassium 
hexachloroosmate (K2OsCl6), contoured at 1.0 σ. The anomalous difference Fourier maps of the 
various heavy metal derivatives (panel A) are overlaid and contoured at 3.5 σ. (C) Close-up view of a 
representative section of the experimental electron density map from panel B overlaid with a stick 
representation of the final model. 
  
65
66
 Fig. S30. 
Crystal packing interactions in the CNT•Nic96R1•sAB-158 crystals. (A, B) Crystal packing 
interactions in the CNT•Nic96R1•sAB-158 crystal shown in two different orientations. Each asymmetric 
unit is composed of two CNT•Nic96R1•sAB-158 complexes that dimerize in a cross-handshake fashion. 
The major crystal contact is formed by an interaction between sAB-158 molecules (blue and orange) 
from adjacent asymmetric units along the c axis. Two additional minor crystal contacts are formed by 
CNT-CNT interactions along the a and b axes. CNT•Nic96R1 complexes of one asymmetric unit are 
colored in green and magenta and their symmetry mates in light and dark gray. As references, units cell 
diagrams are shown to indicate the orientation of each view. The Insets mark the locations of the three 
crystal contact regions that are enlarged and shown in surface representation. 
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 Fig. S31. 
Multispecies sequence alignment of the CNT coiled-coil segments. Sequences of the three coiled-
coil segments of (A) Nup57, (B) Nsp1 and (C) Nup49 from C. thermophilum, S. cerevisiae, and 
H. sapiens were aligned based on the secondary structure elements observed in the CNT•Nic96R1 
structure and colored by sequence similarity according to the BLOSUM62 (Blocks Substitution Matrix) 
matrix from white (less than 40 % similarity), to yellow (40 % similarity), to red (100 % identity). The 
numbering is according to the C. thermophilum channel nups. The secondary structure is indicated 
above the sequence as rectangles (α-helices), arrows (β-strands), and lines (unstructured regions). 
Gray dots indicate residues with no observed electron density in the crystal structure, which are 
presumed disordered. Secondary structure elements are colored according to Figure 4A with the 
exception of the Nup57α/β domain (magenta). A yellow dot in the secondary structure plot of Nup57 (A) 
indicates the position of Q473 and Y293, which are used as positional markers in the structural 
comparison of Nup57CCS3* and hsNup57CCS3* (Figure S23E). Residues of the EVPIP mutant are 
indicated by red dots in the secondary structure plot of Nup49 (panel C). A black dot and a black bar 
indicate the position of the Y420F mutant and the residues removed in the ΔC417 mutant of 
hsNup49CCS2+3*, which increases the abundance (Figure S26, A to C) and abolishes the formation 
(Figure S26, D and E) of higher homo-oligomeric states, respectively. 
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 Fig. S32. 
Multispecies sequence alignment of full-length Nup57. Sequences from six diverse fungal species 
were aligned and colored by sequence similarity according to the BLOSUM62 matrix from white (less 
than 40 % similarity), to yellow (40 % similarity), to red (100 % identity). The numbering is according to 
C. thermophilum proteins. The secondary structure is indicated above the sequence as rectangles (α-
helices), arrows (β-strands), and lines (unstructured regions). Gray dots indicate residues with no 
observed electron density in the crystal structure, which are presumed disordered. Secondary structure 
elements of Nup57 are colored according to Figure 4. 
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 Fig. S33. 
Multispecies sequence alignment of full-length Nsp1. Sequences from six species were aligned 
and colored by sequence similarity according to the BLOSUM62 matrix from white (less than 40 % 
similarity), to yellow (40 % similarity), to red (100 % identity). The numbering is according to 
C. thermophilum proteins. The secondary structure is indicated above the sequence as rectangles (α-
helices), arrows (β-strands), and lines (unstructured regions). Gray dots indicate residues with no 
observed electron density in the crystal structure, which are presumed disordered. Secondary structure 
elements of Nsp1 are colored according to Figure 4. 
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 Fig. S34. 
Multispecies sequence alignment of full-length Nup49. Sequences from six diverse fungal species 
were aligned and colored by sequence similarity according to the BLOSUM62 matrix from white (less 
than 40 % similarity), to yellow (40 % similarity), to red (100 % identity). The numbering is according to 
C. thermophilum proteins. The secondary structure is indicated above the sequence as rectangles (α-
helices), arrows (β-strands), and lines (unstructured regions). Gray dots indicate residues with no 
observed electron density in the crystal structure, which are presumed disordered. Secondary structure 
elements of Nup49 are colored according to Figure 4. 
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 Fig. S35. 
Removal of the Nup57 α /β  insertion domain results in non-stoichiometric higher-order CNT 
oligomers. (A) Alignment of the putative three-stranded coiled-coil trigger sequences of Nsp1 (green), 
Nup49 (yellow) and Nup57 (blue) is shown. The consensus sequence is depicted in red (X, any 
residue) (36). (B) Domain structures of H. sapiens and C. thermophilum Nup57. Bars above the domain 
structures indicate the domain boundaries of intact Nup57 as observed in the CNT•Nic96R1•sAB-158 
crystal structure and of rnNup57 and hsNup57 fragments that were reported previously to form various 
vastly different CNT oligomerization states in solution (22, 23, 26, 28). (C) CNT•Nic96R1•sAB-158 
structure is shown in cartoon representation colored according to Figure 4. The Nup57 α/β insertion 
domain and flanking coiled-coil regions that were excluded in previous mammalian CNT reconstitutions 
are colored in magenta. Hydrophobic residues in the coiled-coil center are represented in ball-and-stick 
representation. The location of the putative three-stranded coiled-coil trigger sequences is highlighted 
on the bottom. For clarity, sAB-158 was removed from the illustration. (D) Model of the CNT lacking an 
N-terminal Nup57 region that encodes the α/β insertion domain and flanking coiled-coil regions, 
corresponding to the mammalian Nup57 fragments used in previous studies. (E) SEC-MALS profiles of 
a C. thermophilum CNT variant using a Nup57 fragment that lacks the N-terminal coiled-coil region and 
the α/β insertion domain (residues 146-319) at three different concentrations. Measured molecular 
masses are indicated for the peak fractions. Gray bar indicates fractions that were resolved on SDS-
PAGE gels and visualized by Coomassie staining. Asterisks indicate degradation products or 
contaminations. MALS and SDS-PAGE analysis establish that the removal of the Nup57 α/β insertion 
domain results in a CNT that adopts various different oligomeric states in solution, as previously 
observed for the mammalian truncated CNT (22, 23, 26, 28). 
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 Fig. S36. 
Identification of CNT mutations that disrupt binding to the IRC. (A-F) SEC-MALS and SDS-PAGE 
analysis corresponding to Figure 5. SEC-MALS profiles of mutant CNT or Nup192TAIL•SUMO-Nic96R1-R2 
complexes are shown individually (blue and red) and after their preincubation (green). Measured 
molecular masses are indicated for the peak fractions. Gray bars indicate fractions that were resolved 
on SDS-PAGE gels and visualized by Coomassie staining. 
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 Fig. S37. 
Nup49 PP and EVPIP mutants decrease CNT thermostability. Wild type CNT and CNT carrying 
either the Nup49 PP or EVPIP mutant were incubated at the indicated temperatures for 30 minutes 
prior to centrifugation. Soluble (S) and pelleted (P) fractions were analyzed by SDS-PAGE and 
visualized by Coomassie staining. Red arrows indicate temperature increment at which in vitro 
aggregation ensued. 
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 Fig. S38. 
The human NPC can accommodate the 60S pre-ribosomal particle. A top view of the cryoelectron 
tomography reconstruction of the human NPC is shown (EMD 2444; gray). The central transport 
channel is large enough to accommodate (A) the 60S pre-ribosomal particle (EMD 2528; blue) and (B) 
eleven Cse1•Kap-α•RanGTP nuclear export complexes (PDB ID: 1WA5) (2, 39, 65). 
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 Table S1. 
SEC-MALS analysis 
Figure Nucleoporin or nucleoporin complex Experimental 
Mass (kDa) 
Theoretical 
Mass (kDa) 
Stoichiometry 
Fig. 1B 
Fig. S1A 
CNT•Nic96 180 187 equimolar 
Nup192•Nup145N 250 239 equimolar 
Nup192•Nup145N •CNT•Nic96 425 426 equimolar 
Fig. 1C 
Fig. S1B 
CNT•Nic96•Nup192•Nup53 320 424 below measurement 
limit 
Nup82•SUMO-Nup159T•Nup145N 110 123 equimolar 
Nup82•SUMO-Nup159T•Nup145N•CNT•Nic96•Nup192 
•Nup53 
440 547 below measurement 
limit 
Fig. 1D 
Fig. S1C 
CNT•Nup192•Nup145N•SUMO-Nic96R1-R2 291 345 below measurement 
limit 
Nic96SOL 75 81 n/a 
CNT•Nup192•Nup145N•SUMO-Nic96R1-R2 •Nic96SOL 301, 74 426 no interaction 
Fig. 1E 
Fig. S1D 
CNT 74 77 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2 69 72 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2•CNT 135 149 equimolar 
Fig. 1F 
Fig. S1E 
CNT 74 77 equimolar 
SUMO-Nic96R1 18 18 n/a 
CNT•SUMO-Nic96R1 87, 18 95 equimolar 
Fig. 1G 
Fig. S1F 
Nup192TAIL 39 41 n/a 
SUMO-Nic96R2 18 19 n/a 
Nup192TAIL•SUMO-Nic96R2 54, 19 60 equimolar 
Fig. 1H 
Fig. S1G 
CNT 68 77 equimolar 
Nup192•Nup145N•Nic96R2-SOL 358 336 equimolar 
Nup192•Nup145N•Nic96R2-SOL•CNT 360, 73 413 no interaction 
Fig. 1I 
Fig. S1H 
CNT 70 77 equimolar 
Nup192•Nup53•Nic96R2-SOL 355 333 equimolar 
Nup192•Nup53•Nic96R2-SOL•CNT 350, 70 410 no interaction 
Fig. S2A Nup82NTD•SUMO-Nup159T 79 80 equimolar 
Nup145N 42 42 n/a 
Nup82NTD•SUMO-Nup159T•Nup145N 110 122 equimolar 
Fig. S2B Nup82NTD•SUMO-Nup159T 79 80 equimolar 
Nup145NAPD 16 16 n/a 
Nup82NTD•SUMO-Nup159T•Nup145NAPD 97 96 equimolar 
Fig. S2D CNT 71 77 equimolar 
Nup145N 48 42 n/a 
CNT•Nup145N 105 119 equimolar 
Fig. S2F CNT•Nup145N 78 119 equimolar 
Nup192 182 197 n/a 
Nup192• CNT•Nup145N 210, 76 316 no interaction 
Fig. S4A CNT 74 77 equimolar 
SUMO-Nic96R2 18 19 n/a 
CNT•SUMO-Nic96R2 75, 18 96 No interaction 
Fig. S4B Nup192TAIL 39 41 n/a 
SUMO-Nic96R1 18 18 n/a 
Nup192TAIL•SUMO-Nic96R1 29 59 No interaction 
Fig. S4C CNT 74 77 equimolar 
Nup192TAIL 39 41 n/a 
CNT•Nup192TAIL 74, 40 118 No interaction 
Fig. 3B 
Fig. S15B 
CNT 71 77 equimolar 
SUMO-Nic96R1  18 18 n/a 
Preincubation - LLLL 18, 70 95 no interaction 
Preincubation - wt 17, 80 95 equimolar 
Fig. S15A CNT 71 77 equimolar 
SUMO-Nic96R1 wt and truncations 18 18, 17, 18, 17 n/a 
Preincubation - wt 17, 80 95 equimolar 
Preincubation - truncations 18, 18, 18,  
73, 70, 68 
94-95 sub-stoichiometric / 
no interaction 
Fig. S18C CNT 1 mg/ml 147, 71 77 for monomer equimolar 
CNT 10 mg/ml 131, 69 77 for monomer equimolar 
CNT 30 mg/ml 136, 73 77 for monomer equimolar 
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 Figure Nucleoporin or nucleoporin complex Experimental 
Mass (kDa) 
Theoretical 
Mass (kDa) 
Stoichiometry 
Fig. S18D CNT 147, 71 77 for monomer equimolar 
SUMO-Nic96R1 --- 18 n/a 
CNT•SUMO-Nic96R1 183, 87 95 for monomer equimolar 
Fig. S15A CNT 71 77 equimolar 
SUMO-Nic96R1 wt and truncations 18 18, 17, 18, 17 n/a 
Preincubation - wt 17, 80 95 equimolar 
Preincubation - truncations 18, 18, 18,  
73, 70, 68 
94-95 sub-stoichiometric / 
no interaction 
Fig. S22B hsNup49 CCS2+3*  22, 23, 25, 29, 
33, 36, 37, 40 
10 for monomer n/a 
Fig. S22C hsNup57 CCS3* 18 5 for monomer n/a 
hsNup49 CCS2+3* 25, 40 10 for monomer n/a 
hsNup57 CCS3*• hsNup49 CCS2+3* 24, 57 various polydisperse 
Fig. S23B hsNup57 CCS3* 18 5 for monomer tetramer 
Fig. S23C Nup57 CCS3* 8 4 for monomer dimer 
Fig. S25B hsNup57 CCS3* --- 5 for monomer n/a 
hsNup49 CCS2+3* --- 10 for monomer n/a 
hsNup57 CCS3*• hsNup49 CCS2+3* 20, 24, 26, 49, 
53, 54 
various polydisperse 
Fig. S25C hsNup57 CCS3* --- 5 for monomer n/a 
hsNup49 CCS2+3* --- 10 for monomer n/a 
Preincubation 21, 23, 25, 26, 
46, 51, 57, 57 
various polydisperse 
Fig. S26B hsNup57 CCS3* --- 5 for monomer n/a 
hsNup49 CCS2+3* --- 10 for monomer n/a 
hsNup49 CCS2+3*, Y420F --- 10 for monomer n/a 
hsNup57 CCS3*•hsNup49 CCS2+3* 25, 57 various polydisperse 
hsNup57 CCS3*•hsNup49 CCS2+3*, Y420F 29, 63 various polydisperse 
Fig. S26C hsNup49 CCS2+3* 25, 40 10 for monomer polydisperse 
hsNup49 CCS2+3*, Y420F 33, 54 10 for monomer polydisperse 
Fig. S26D hsNup49 CCS2+3*, Y420F 28, 30, 32, 36, 
37, 40, 47, 54 
10 for monomer polydisperse 
Fig. S26E hsNup49 CCS2+3* ΔC417 17, 18, 18, 19 10 for monomer polydisperse 
Fig. S27F CNT•SUMO-Nic96R1 92 95 n/a 
CNT•SUMO-Nic96R1•MB6 116 119 equimolar 
CNT•SUMO-Nic96R1•MB6•MB9 133 143 equimolar 
Fig. S27G CNT•Nic96•SUMO-MB6•SUMO-MB9 180 236 equimolar 
Nup192•Nup145N 244 239 equimolar 
CNT•Nic96•SUMO-MB6•SUMO-MB9• Nup192•Nup145N 417 475 equimolar 
Fig. S28A CNT 63 77 equimolar 
CNT•sAB158 109 128 equimolar 
CNT•sAB158•sAB160 162 179 equimolar 
Fig. S28B CNT•sAB158 111 128 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2 77 72 equimolar 
CNT•sAB158•Nup192TAIL•SUMO-Nic96R1-R2 158 200 equimolar 
Fig. 5C 
Fig. S36B 
CNT EPP 73 77 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2 63 72 equimolar 
Preincubation - wt 135 149 equimolar 
Preincubation – EPP mutant 73, 64 149 no interaction 
Fig. S36C CNT PP 75 77 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2 65 72 equimolar 
Preincubation 72, 61 149 below measurement 
limit 
Fig. S36D CNT T378E 69 77 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2 65 72 equimolar 
Preincubation  120 149 equimolar 
Fig. S36E CNT I393P 70 77 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2 65 72 equimolar 
Preincubation 120 149 equimolar 
Fig. S36F CNT S442P 68 77 equimolar 
Nup192TAIL•SUMO-Nic96R1-R2 65 72 equimolar 
Preincubation 119 149 equimolar 
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Table S2. 
Crystallographic analysis of Nup188TAIL, Nup192TAIL, and Nup82NTD•Nup159T•Nup145NAPD structures 
     
Data collection     
Protein(s) 
 
 
Nup192TAIL 
 
 
Nup188TAIL 
 
 
Nup82NTD 
Nup159T 
Nup145NAPD 
Nup82NTD 
Nup159T 
Nup145NAPD 
     
PDB code 5CWV 5CWU 5CWW  
Synchrotron SSRLa APSb APS SSRL 
Beamline BL12-2 23ID-D 23ID-D BL12-2 
Space group P212121 P1 C2 C2 
Cell parameters     
a (Å) 
b (Å) 
c (Å) 
64.7 
114.4 
114.7 
65.2 
65.3 
155.5 
122.3 
108 
69.6 
122.1 
108.2 
69.6 
α (°) 
β (°) 
γ (°) 
90.0 
90.0 
90.0 
90.0 
89.9 
90.0 
90.0 
108.6 
90.0 
90.0 
108.4 
90.0 
     
 Se peak Se peak Native Se peak 
Wavelength (Å) 0.9793 0.9794 1.0000 0.97940 
Resolution (Å) 20.0 – 3.15 20.0 – 3.35 30.0 – 2.2 40.0 – 2.5 
Rsym (%)c 8.1 (100.4) 7.0 (98.6) 8.4 (154.6) 6.9 (68.4) 
Rpim (%)c 2.5 (34.6) 2.6 (38.3) 3.2 (69.4) 2.9 (28.5) 
CC1/2 (%)c 99.9 (69.2) 100.0 (80.4) 99.9 (58.4) 99.9 (86.4) 
<I> / <σI>c 28.3 (2.2) 34.0 (2.1) 13.6 (1.2) 15.0 (2.5) 
Completeness (%)c 99.5 (99.2) 99.3 (98.6) 99.0 (97.1) 98.6 (98.1) 
No. observations 183,279 294,471 300,689 202,782 
No. unique reflectionsc,d 28,157 (2,819) 74,517 (7,493) 43,372 (6,846) 57,257 (9,135) 
Redundancyc 12.2 (9.2) 7.9 (7.7) 6.9 (6.7) 6.9 (7.0) 
Wilson B factor 113 130 53 68 
     
Refinement     
Resolution (Å) 20.0 – 3.15 20.0 – 3.35 30.0 – 2.2  
No. reflections total 28,095 72,752 43,203  
No. reflections test set 2,843 (10.1%) 3,632 (5.0%) 2,959 (6.8%)  
Rwork / Rfree 18.5 / 24.1 24.6 / 27.9 18.5 / 21.3  
No. atoms 4,167 18,312 5,785  
    Protein 4,167 18,264 5,614  
    Ligand 0 48 0  
    Water 0 0 171  
B-factors     
    Protein 121 104 75  
    Ligand N/A 80 N/A  
    Water N/A N/A 61  
R.m.s. deviations     
    Bond lengths (Å) 0.003 0.004 0.003  
    Bond angles (°) 0.6 0.7 0.8  
     
Ramachandran plote     
    Favored (%) 94.2 89.4 97.1  
    Additionally allowed (%) 5.8 10.6 2.9  
    Outliers (%) 0.0 0.0 0.0  
     
a SSRL, Stanford Synchrotron Radiation Lightsource 
b APS, Advanced Photon Source 
c Highest-resolution shell is shown in parentheses 
d Unique reflections distinguish anomalous Friedel pairs 
e As determined by MolProbity (61) 
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Table S3. 
Crystallographic analysis of channel nup fragment structures 
        
Data collection        
Protein 1 hsNup57CCS3* hsNup57CCS3* hsNup49CCS2+3* hsNup49CCS2+3* hsNup49CCS2+3* Nup57CCS3* Nup57CCS3* I289M 
Protein 2    hsNup57CCS3* hsNup57CCS3*   
Stoichiometry Homotetramer Homotetramer Homotetramer 2:2 stoichiometry 1:2 stoichiometry Homodimer Homotetramer 
PDB code 4JNV 4JNU 4JQ5 4JO7 4JO9 5CWT  
Synchrotron SSRLa ALSb SSRL SSRL SSRL SSRL SSRL 
Beamline BL12-2 BL8.2.1 BL12-2 BL12-2 BL12-2 BL12-2 BL12-2 
Space group C2 P21 P1 P1 P4122 P212121 P212121 
Cell parameters        
    a (Å) 
    b (Å) 
    c (Å) 
70.5 
36.6 
63.2 
39.9 
45.1 
46.4 
63.8 
77.1 
77.2 
47.7 
47.7 
71.3 
55.5 
55.5 
191.2 
42.3 
42.4 
138.7 
42.2 
42.2 
139.6 
    α (°) 
    β (°) 
    γ (°) 
90.0 
104.4 
90.0 
90.0 
113.8 
90.0 
120.0 
90.1 
89.9 
88.9 
83.4 
81.4 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
 Se peak Native Native Se peak Native Native Se peak 
Wavelength (Å) 0.9794 1.0000 1.0000 0.9794 1.0000 1.00010 0.9792 
Resolution (Å) 20.0 – 1.85 20.0 – 1.45 20.0 – 2.2 50.0 – 1.75 50.0 – 2.5 20.0 – 2.5 20.0 – 2.75 
Rsym (%)c 9.6 (54.4) 9.9 (59.0) 6.4 (52.8) 14.0 (80.2) 13.6 (74.3) 4.3 (24.2) 15.1 (84.4) 
Rpim (%)c 4.0 (24.7) 4.1 (30.2) 3.9 (32.1) 8.9 (52.7) 3.5 (22.6) 1.4 (7.0) 4.7 (28.4) 
CC1/2 (%)c 99.2 (88.6) 99.1 (88.7) 99.3 (90.8) 99.0 (46.4) 99.9 (93.8) 99.9 (99.3) 98.9 (91.6) 
<I> / <σI>c 16.0 (4.1) 15.5 (2.2) 17.8 (2.1) 10.0 (2.2) 19.8 (2.1) 58.3 (6.3) 14.8 (2.7) 
Completeness (%)c 97.3 (97.2) 97.2 (81.6) 97.3 (87.7) 97.5 (95.3) 98.8 (89.1) 98.0 (88.2) 99.7 (98.8) 
No. observations 82,655 174,150 242,553 205,417 169,333 136,374 79,570 
No. unique reflectionsc,d 25,273 (2,494) 26,320 (2,198) 63,140 (5,724) 117,121 (11,189) 11,003 (953) 8,970 (759) 12,635 (1,297) 
Redundancyc 6.3 (5.3) 6.6 (3.6) 3.8 (3.5) 3.4 (3.1) 15.4 (10.0) 15.2 (10.2) 11.4 (8.3) 
Wilson B factor 32 18 45 17 46 32 71 
        
Refinement        
Resolution (Å) 20.0 – 1.85 20.0 – 1.45 20.0 – 2.2 50.0 – 1.75 50.0 – 2.5 20.0 – 2.5  
No. reflections total 25,266 26,274 63,070 116,939 10,891 8,126  
No. reflections test set 2,508 (9.93%) 1,990 (7.57%) 1,990 (3.16%) 3,925 (3.36%) 1,092 (10.0%) 809 (9.9%)  
Rwork / Rfree 23.7 / 27.7 18.3 / 21.8 28.5 / 29.3 18.6 / 21.4 24.7 / 29.4 24.1 / 29.3  
No. atoms 1,108 3,121 8,526 4,592 1,355 1,323  
    Protein 1,086 2,989 8,526 4,138 1,338 1,305  
    Ligand 0 0 0 0 0 0  
    Water 22 132 0 454 17 18  
B-factors        
    Protein 30 25 51 19 89 58  
    Ligand N/A N/A N/A N/A N/A N/A  
    Water 30 37 N/A 32 61 54  
R.m.s. deviations        
    Bond lengths (Å)  0.009 0.007 0.002 0.008 0.002 0.002  
    Bond angles (°) 0.9 1.0 0.5 0.8 0.4 0.4  
        
Ramachandran plote        
    Favored (%) 99.2 100.0 96.1 99.2 97.4 99.3  
    Additionally allowed (%) 0.8 0.0 3.9 0.8 2.6 0.7  
    Outliers (%) 0.0 0.0 0.0 0.0 0.0 0.0  
        
a SSRL, Stanford Synchrotron Radiation Lightsource 
b ALS, Advanced Light Source 
c Highest-resolution shell is shown in parentheses 
d Unique reflections distinguish anomalous Friedel pairs 
e As determined by MolProbity (61) 
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Table S4. 
Crystallographic analysis of the CNT•Nic96R1•sAB-158 structure 
        
Data collection K2OsCl6g K2OsCl6g K2OsO4 SeMeth PCMB EMTS Native 
Synchrotron SSRLa SSRL SSRL SSRL SSRL SSRL APSb 
Beamline BL12-2 BL12-2 BL12-2 BL12-2 BL12-2 BL12-2 23ID-D 
Space group P212121 P212121 P212121 P212121 P212121 P212121 P212121 
Cell dimensions        
    a (Å) 
    b (Å) 
    c (Å) 
123.2 
162.8 
212.9 
123.2 
162.8 
212.9 
122.5 
162.8 
215.2 
122.9 
162.2 
214.0 
123.3 
163.8 
214.5 
121.5 
162.4 
215.5 
123.7 
162.9 
214.1 
    α (°) 
    β (°) 
    γ (°) 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
90.0 
        
 Os peak Os peak Os peak Se peak Hg peak Hg peak Native 
Wavelength (Å) 1.1400 1.1400 1.1400 0.9793 1.0078 1.0054 1.0330 
Resolution (Å) 50.0 – 3.77 50.0 – 3.95 40.0 – 4.4 40.0 – 3.77 40.0 – 5.6 40.0 – 4.8 40.0 – 3.95 
Rmeas (%)c 20.4 (585.7) 17.2 (308.4) 16.3 (302.1) 18.1 (495.9) 11.9 (330.3) 15.5 (304.6) 11.3 (373.9) 
Rpim (%)c 3.2 (91.9) 2.7 (53.1) 3.1 (63.7) 3.5 (99.8) 3.3 (95.8) 4.2 (89.3) 2.2 (83.2) 
CC1/2 (%)c 100.0 (54.4) 100.0 (74.6) 100.0 (57.2) 100.0 (57.6) 99.9 (53.0) 99.0 (64.7) 100.0 (59.5) 
<I> / <σI>c 17.0 (1.00) 19.36 (1.84) 14.26 (1.42) 14.49 (1.01) 14.31 (1.02) 11.68 (1.16) 17.79 (1.17) 
Completeness (%)c 99.9 (99.9) 99.9 (100.0) 99.7 (100.0) 99.8 (99.8) 99.4 (99.8) 98.7 (97.9) 99.5 (98.9) 
No. of observations 1,765,669 1,538,483 740,306 1,167,642 181,671 283,261 1,024,643 
No. of unique reflectionsc,d 83,402 (13,626) 72,513 (11,756) 52,614 (8,566) 83,196 (13,534) 25,719 (4,067) 39,850 (6,414) 38,491 (6,087) 
Redundancyc 40.2 (40.2) 40.2 (40.4) 26.5 (27.7) 26.7 (27.1) 13.1 (13.8) 13.4 (13.1) 26.6 (26.0) 
Wilson B factor 178 169 235 160 413 288 204 
        
Refinement        
Resolution (Å) 50 – 3.77       
No. of reflections 83,342       
No. of reflections test set 3,789 (4.56%)       
Rwork / Rfree 22.9 / 26.5       
No. atoms 16,564       
    Protein 16,562       
    Ions 2       
R.m.s deviations        
    Bond lengths (Å) 0.003       
    Bond angles (°) 0.7       
B-factorse        
    Protein 242       
    Ions 299       
Ramachandran plotf        
    Favored (%) 93.1       
    Additionally allowed (%) 6.9       
    Outliers (%) 0.0       
        
a SSRL, Stanford Synchrotron Radiation Lightsource 
b APS, Advanced Photon Source 
c Highest-resolution shell is shown in parentheses 
d Unique reflections distinguish anomalous Friedel pairs 
e B-factors include overall B-factor of the crystal 
f As determined by MolProbity (61) 
g As reference, data processing statistics using different high resolution cutoffs are indicated. 
h Representative statistics for all 23 SeMet datasets (wild type and 22 methionine mutants) 
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Table S5. 
Bacterial expression constructs and expression conditions 
# 
 
Protein 
 
Residues 
 
Expression vector 
 
Restriction sites 
5’, 3’ 
N-terminal 
overhang 
C-terminal 
overhang 
Expression 
conditions 
1t hsNup49 CCS2+3* 341-428 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
2 hsNup49 341-428 (Y420F) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
3t hsNup57 CCS3* 453-491 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
4t hsNup57 453-491 (I478M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
5t Nsp1 
Nup57 
467-674 
74-319 
pETDuet1 NcoI/NotI 
NdeI/XhoI 
None 
M 
none 
none 
18 °C / 18 hours 
6 Nsp1 
Nup57 Δα/β 
467-674 
146-319 
pETDuet1 NcoI/NotI 
NdeI/XhoI 
None 
M 
none 
none 
18 °C / 18 hours 
7t,n Nsp1 
Nup57 
467-674 (L527M) 
74-319  
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
8t,n Nsp1 
Nup57 
467-674 (L548M) 
74-319  
pETDuet1 NdeI/XhoI None 
M 
none 18 °C / 18 hours 
9t,n Nsp1 
Nup57 
467-674 (A628M)  
74-319  
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
10t,n Nsp1 
Nup57 
467-674  
74-319 (I82M) 
pETDuet1 NdeI/XhoI None 
M 
none 18 °C / 18 hours 
11t,n Nsp1 
Nup57 
467-674  
74-319 (H109M) 
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
12t,n Nsp1 
Nup57 
467-674  
74-319 (L113M) 
pETDuet1 NdeI/XhoI None 
M 
none 18 °C / 18 hours 
13t,n Nsp1 
Nup57 
467-674  
74-319 (E127M) 
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
14t,n Nsp1 
Nup57 
467-674  
74-319 (I138M) 
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
15t,n Nsp1 
Nup57 
467-674  
74-319 (L198M) 
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
16t,n Nsp1 
Nup57 
467-674  
74-319 (I233M) 
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
17t,n Nsp1 
Nup57 
467-674 
74-319 (L253M) 
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
18t,n Nsp1 
Nup57 
467-674  
74-319 (V303M) 
pETDuet1 NcoI/NotI None 
M 
none 18 °C / 18 hours 
19 Nsp1 467-678 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
20 Nup57 74-326 pGEX-6P1 BamHI, NotI GPLGS none 18 °C / 18 hours 
21t Nup57 265-317 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
22t Nup57 265-317 (I289M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
23t Nup49 246-470 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
24t,n Nup49 246-470 (I263M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
25t,n Nup49 246-470 (H276M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
26t,n Nup49 246-470 (L301M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
27t,n Nup49 246-470 (A307M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
28t,n Nup49 246-470 (L332M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
29t,n Nup49 246-470 (E438M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
30# Avi-Nup49 246-470 pET28a-PreS BamHI, NotI GPLMSGLNDIFEAQKI
EWHEGSAGGSGHM 
none 18 °C / 18 hours 
31 Nup49 E 246-470 (T378E) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
32 Nup49 P1 246-470 (I393P) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
33 Nup49 P2 246-470 (S442P) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
34 Nup49 PP 246-470 (I393P, S442P) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
35 Nup49 EPP 246-470 (T378E, I393P, 
S442P) 
pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
36 Nup49 EVPIP 246-470 (T378E, T292V, 
I393P, L400I, S442P) 
pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
37 Nic96 110-1112 pET28a-Sumo BamHI, NotI S AAALEHHHHHH 18 °C / 18 hours 
38# Nic96 139-201 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
39t,# Nic96 R1 139-180 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
40t,n Nic96 R1 139-180 (L178M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
41t,n Nic96 R1 139-180 (L140M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
42t,n Nic96 R1 139-180 (L161M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
43t,n Nic96 R1 139-180 (L164M) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
44 Nic96 139-164 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
45 Nic96 139-171 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
46 Nic96 146-180 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
47 Nic96 156-180 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
48 Nic96 165-180 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
49 Nic96 139-180 (L168A, L171A, 
L175A, L178A) 
pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
50 Nic96 139-180 (L168A, L171A) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
51 Nic96 139-180 (L175A, L178A) pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
52 Nic96 R1-R2 139-301 pET-MCN-Sumo BamHI, NotI S none N/A 
53 Nic96 R2-SOL 245-1112 pGEX-6P1 BamHI, NotI GPHM none 23 °C / 18 hours 
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# 
 
Protein 
 
Residues 
 
Expression vector 
 
Restriction sites 
5’, 3’ 
N-terminal 
overhang 
C-terminal 
overhang 
Expression 
conditions 
54 Nic96 SOL 391-1112 pET28a-SUMO BamHI, NotI S none 18 °C / 18 hours 
55 Nic96 R2 245-301 pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
56 Nic96 R2 245-301 (F275A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
57 Nic96 R2 245-301 (D276A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
58 Nic96 R2 245-301 (F278A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
59 Nic96 R2 245-301 (N282A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
60 Nic96 R2 245-301 (L285A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
61 Nic96 R2 245-301 (W287A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
62 Nic96 R2 245-301 (I294A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
63 Nic96 R2 245-301 (F298A) pET-MCN-Sumo BamHI, NotI S none 37 °C / 2 hours 
64 MB1 1-91 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
65 MB2 1-93 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
66 MB3 1-91 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
67 MB4 1-93 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
68 MB5 1-93 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
69 MB6 1-92 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
70 MB7 1-91 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
71 MB8 1-93 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
72 MB9 1-91 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
73 MB10 1-93 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
74t sAB-158-LC 
sAB-158-HC 
1-204 
1-258 
pSV4 NcoI, SalI none VDKKVEPKSCDKT 
HTGGSHHHHHH 
37 °C / 2 hours 
75 sAB-160-LC 
sAB-160-HC 
1-204 
1-258 
pSV4 NcoI, SalI none VDKKVEPKSCDKT 
HTGGSHHHHHH 
37 °C / 2 hours 
76 Nup145N 606-993 pET28a-Sumo BamHI, NotI S none 23 °C / 18 hours 
77t Nup145N APD 858-993 pET28a-PreS NdeI, XhoI GPHM none 23 °C / 18 hours 
78 Nup53 ΔC 1-361 pET28a-Sumo BamHI, XhoI S LEHHHHHH 23 °C / 18 hours 
79t Nup82 NTD 1-595 pET28a-PreS NdeI, NotI GPH none 18 °C / 18 hours 
80t Nup159 T 1440-1481 pET28a-Sumo BamHI, NotI S none 18 °C / 18 hours 
81 Nup192 1-1756 pET28a-PreS NdeI, NotI GPLMSGLNDIFEAQKI
EWHEGSAGGSGH 
none 23 °C / 18 hours 
82 Nup192 CTD 944-1756 pET28a-PreS NdeI, NotI GPHM none 23 °C / 18 hours 
83t Nup192 TAIL 1397-1756 pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
84* Nup192 TAIL 1397-1756 (L1403E, 
I1427E) 
pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
85 Nup192 TAIL 1397-1756 (L1597A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
86 Nup192 TAIL 1397-1756 (F1602A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
87 Nup192 TAIL 1397-1756 (F1602W) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
88 Nup192 TAIL 1397-1756 (F1611A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
89 Nup192 TAIL 1397-1756 (D1614A, 
P1615A, E1616A) 
pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
90 Nup192 TAIL 1397-1756 (D1614A, 
E1616A) 
pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
91 Nup192 TAIL 1397-1756 (F1664A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
92 Nup192 TAIL 1397-1756 (F1664W) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
93 Nup192 TAIL 1397-1756 (V1673A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
94 Nup192 TAIL 1397-1756 (L1676A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
95 Nup192 TAIL 1397-1756 (K1677A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
96 Nup192 TAIL 1397-1756 (M1727A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
97 Nup192 TAIL 1397-1756 (I1730A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
98 Nup192 TAIL 1397-1756 (F1735A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
99 Nup192 TAIL 1397-1756 (Y1738A) pET28a-PreS NdeI, NotI GPHM none 37 °C / 2 hours 
100t Nup188 TAIL 1447-1858 pET28a-SUMO BamHI, NotI SM none 18 °C / 18 hours 
* Nup192 TAIL used for SEC-MALS analyses harbored two mutations to prevent non-physiological dimerization. These mutants were designed based on observed 
crystal packing interactions in the Nup192TAIL structure 
t Constructs that were used for crystallization 
# Constructs that were used for sAB and MB selection 
n Constructs that were used for ascertaining sequence register by Se-Met labeling 
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Table S6. 
Protein purification protocols 
Protein(s) 
 
Expression 
constructs 
Purification step 
 
Buffer A 
 
Buffer B 
 
Nup192 TAILt 
 
Individual 
(#83) 
1. Ni-NTA 
2. Dialysis/Cleavage 
3. Ni-NTA 
4. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
Ni-A3, 5 mM β-ME / PreS 
Ni-A3, 5 mM β-ME 
SEC-B, 1 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
N/A 
His6-Nup192 TAIL 
wild type and mutants 
 
Individual 
(#83, #85-99) 
1. Ni-NTA 
2. Dialysis 
3. HiTrap Q HP 
4. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A1, pH 9.0, 5 mM β-ME 
IEX-A1, pH 9.0, 1 mM DTT 
SEC-B, 1 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
IEX-B, pH 9.0, 1 mM DTT 
N/A 
His6-Nup192 TAIL•SUMO-Nic96 R1-R2 
 
Co-expression 
(#84+#52) 
1. Ni-NTA 
2. Dialysis 
3. HiTrap Q HP 
4. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A1, pH 9.0, 5 mM β-ME 
IEX-A1, pH 9.0, 1 mM DTT 
SEC-B, 1 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
IEX-B, pH 9.0, 1 mM DTT 
N/A 
Nup188 TAILt 
 
Individual 
(#100) 
1. Ni-NTA 
2. Dialysis/Cleavage 
3. Ni-NTA 
4. MonoQ 10/100 GL 
5. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
Ni-A2, 5 mM β-ME / ULP1 
Ni-A2, 5 mM β-ME 
IEX-A2, pH 8.0, 1 mM DTT 
SEC-A, 1 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
IEX-B, pH 8.0, 1 mM DTT 
N/A 
SUMO-Nup188 TAIL 
 
Individual 
(#100) 
1. Ni-NTA 
2. Dialysis 
3. MonoQ 10/100 GL 
4. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM β-ME 
IEX-A2, pH 8.0, 1 mM DTT 
SEC-B, 1 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
IEX-B, pH 8.0, 1 mM DTT 
N/A 
SUMO-Nup188 TAIL•SUMO-Nic96 R1-R2 
 
Co-expression 
(#100+#52) 
1. Ni-NTA 
2. Dialysis 
3. MonoQ 10/100 GL 
4. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM β-ME 
IEX-A2, pH 8.0, 1 mM DTT 
SEC-B, 1 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
IEX-B, pH 8.0, 1 mM DTT 
N/A 
SUMO-Nic96 R1t 
wild type, mutants, and truncations 
Individual 
(#39-#51) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting 
3. HiLoad Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
SEC-A, 5 mM DTT 
SEC-A, 5 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
N/A 
SUMO-Nic96 R2 
wild type and mutants 
Individual 
(#55-63) 
1. Ni-NTA 
2. Dialysis 
3. HiTrap Q HP 
4. HiLoad Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM β-ME 
IEX-A2, pH 8.0, 1 mM DTT 
SEC-B, 1 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
IEX-B, pH 8.0, 1 mM DTT 
N/A 
Nup145N Individual 
(#76) 
1. Ni-NTA 
2. Dialysis/Cleavage 
3. MonoS 5/50 GL 
4. HiLoad Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 7.0, 5 mM DTT / ULP1 
IEX-A2, pH 7.0, 5 mM DTT 
SEC-A, 5 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
IEX-B, pH 7.0, 5 mM DTT 
N/A 
Nup145N APDt Individual 
(#77) 
1. Ni-NTA 
2. Dialysis/cleavage 
3. Ni-NTA 
4. Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM β-ME / PreS 
Ni-A2, 5 mM β-ME 
SEC-A, 5 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
N/A 
Nup53 Individual 
(#78) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiPrep 26/20 Desalting 
5. MonoS 5/50 GL 
6. HiLoad Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
Ni-A1, 5 mM β-ME / ULP1 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 7.0, 5 mM DTT 
IEX-A2, pH 7.0, 5 mM DTT 
SEC-A, 5 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
N/A 
IEX-B, pH 7.0, 5 mM DTT 
N/A 
hsNup49 CCS2+3*t 
wild type and mutant 
Individual 
(#1-2) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiLoad Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
SEC-A, 4 mM β-ME / ULP1 
Ni-A2, pH 8.0, 4 mM β-ME 
SEC-A, 4 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
N/A 
hsNup57 CCS3*t 
wild type and mutant 
Individual 
(#3-4) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiLoad Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
SEC-A, 4 mM β-ME / ULP1 
Ni-A2, pH 8.0, 4 mM β-ME 
SEC-A, 4 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
N/A 
ctNup57 CCS3*t 
wild type and mutant 
Individual 
(#21-22) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiLoad Superdex 75 16/60 PG 
Ni-A1, 5 mM β-ME 
SEC-A, 4 mM β-ME / ULP1 
Ni-A2, pH 8.0, 4 mM β-ME 
SEC-A, 4 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
N/A 
Nic96 SOL Individual 
(#54) 
1. Ni-NTA 
2. Dialysis/Cleavage 
3. Ni-NTA 
4. MonoQ 10/100 GL 
5. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM β-ME / ULP1 
Ni-A2, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM DTT 
SEC-A, 5 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
IEX-B, pH 8.0, 5 mM DTT 
N/A 
avi-Nup192 Individual 
(#81) 
1. Ni-NTA 
2. Dialysis/Cleavage 
3. Ni-NTA 
4. MonoQ 10/100 GL 
5. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM β-ME / PreS 
Ni-A2, pH 8.0, 5 mM β-ME 
IEX-A2, pH 8.0, 5 mM DTT 
SEC-A, 5 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
IEX-B, pH 8.0, 5 mM DTT 
N/A 
CNTt 
wild type 
mutants 
avi-tagged variant 
Met mutants 
Co-expression 
(#5+#23) 
(#5+#31-36) 
(#5+#12) 
(#5+#24-29) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiTrap Q HP 
5. HiLoad Superdex 200 16/60 PG 
Ni-A1, 4 mM β-ME 
IEX-A2, pH 8.0, 4 mM β-ME / ULP1 
Ni-A2, pH 8.0, 4 mM β-ME  
IEX-A2, pH 8.0, 5 mM DTT 
SEC-A, 5 mM DTT 
Ni-B1, 4 mM β-ME 
N/A 
Ni-B1, 4 mM β-ME 
IEX-B, pH 8.0, 5 mM DTT 
N/A 
Nsp1 Individual 
(#19) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
SEC-A, 5 mM β-ME / ULP1 
Ni-A2, 5 mM β-ME 
SEC-A, 5 mM DTT 
Ni-B1, 5 mM β-ME 
N/A 
Ni-B1, 5 mM β-ME 
N/A 
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Protein(s) 
 
Expression 
constructs 
Purification step 
 
Buffer A 
 
Buffer B 
 
Nup49•Nup57 Co-expression 
(#23+#20) 
1. GST-Sepharose fastflow 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiPrep 26/20 Desalting/Cleavage 
5. Ni-NTA 
6. HiTrap Desalting 
GST-A, 5 mM β-ME 
IEX-A2: pH 8.0, 5 mM β-ME / PreS 
Ni-A2, 5 mM β-ME 
IEX-A2: pH 8.0, 5 mM β-ME / ULP1 
Ni-A2, 5 mM β-ME 
SEC-A, 5 mM β-ME 
GST-B, 5 mM β-ME 
N/A 
Ni-B2, 5 mM β-ME 
N/A 
Ni-B2, 5 mM β-ME 
N/A 
Nup82 NTD•Nup159 Tt Individual 
(#79) 
(#80) 
co-lysis (1:1) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting/Cleavage 
3. Ni-NTA 
4. HiLoad Superdex 200 16/60 PG 
Ni-A1, 5 mM β-ME 
Ni-A1, 5 mM β-ME/ PreS / ULP1 
Ni-A1, 5 mM β-ME 
SEC-A, 5 mM DTT 
Ni-B1, 4 mM β-ME 
N/A 
Ni-B1, 4 mM β-ME 
N/A 
SUMO-MBs Individual 
(#64-73) 
1. Ni-NTA 
2. HiPrep 26/20 Desalting 
Ni-A1, 4 mM β-ME 
SEC-B, 4 mM β-ME 
Ni-B1, 4 mM β-ME 
N/A 
sABs (#74-75) Detailed description in SI methods   
CNT•Nic96 
CNT 
Nic96 
Individual 
(#5+#23) 
(#37) 
co-lysis (1:1) 
Detailed description in SI methods   
Nic96 R2-SOL•avi-Nup192 
Nic96 R2-SOL 
avi-Nup192 
Individual 
(#53) 
(#81) 
co-lysis (1:1) 
Detailed description in SI methods   
CNT•SUMO-Nic96 R1 Biochemical 
reconstitution Detailed description in SI methods   
CNT•Nic96 R1•sAB-158 Biochemical 
reconstitution Detailed description in SI methods   
Nup82 NTD•Nup159 T•Nup145N APD Biochemical 
reconstitution Detailed description in SI methods   
t Constructs that were used for crystallization 
Ni-A1: 20 mM TRIS (pH 8.0), 500 mM NaCl, 20 mM imidazole 
Ni-A2: 20 mM TRIS (pH 8.0), 100 mM NaCl, 20 mM imidazole 
Ni-A3: 20 mM TRIS (pH 8.0), 200 mM NaCl, 20 mM imidazole 
Ni-B1: 20 mM TRIS (pH 8.0), 500 mM NaCl, 500 mM imidazole 
Ni-B2: 20 mM TRIS (pH 8.0), 100 mM NaCl, 500 mM imidazole 
GST-A: 20 mM TRIS (pH 8.0), 300 mM NaCl 
GST-B: 20 mM TRIS (pH 8.0), 300 mM NaCl, 20 mM glutathione 
IEX-A1: 20 mM TRIS, 50 mM NaCl 
IEX-A2: 20 mM TRIS, 100 mM NaCl 
IEX-A3: 20 mM TRIS, 80 mM NaCl 
IEX-B: 20 mM TRIS, 2.0 M NaCl 
SEC-A: 20 mM TRIS (pH 8.0), 100 mM NaCl 
SEC-B: 20 mM TRIS (pH 8.0), 200 mM NaCl 
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Table S7. 
Yeast expression constructs 
Plasmid Protein Residues 
(Mutations) 
Vector Restriction sites 
5’, 3’ 
Selection  
Marker 
Reference 
pRS415-PNop1-eGFP-scNUP192 scNup192 1-1683 pRS415 NotI, SacII LEU2 (8) 
pRS415-PNop1-eGFP-scnup192 ΔTAIL scNup192 1-1316 pRS415 NotI, SacII LEU2 (8) 
pRS415-PNop1-eGFP-scnup192 Y1679A scNup192 1-1683, Y1679A pRS415 NotI, SacII LEU2 this study 
pRS415-PNop1-mCherry-scNUP192 scNup192 1-1683 pRS415 NotI, SacII LEU2 this study 
pRS415-PNop1-mCherry-scnup192 ΔTAIL scNup192 1-1316 pRS415 NotI, SacII LEU2 this study 
pRS415-PNop1-mCherry-scnup192 Y1679A scNup192 1-1683, Y1679A pRS415 NotI, SacII LEU2 this study 
pRS416-PNop1-mCherry-scNUP192 scNup192 1-1683 pRS416 NotI, SacII URA3 (8) 
pRS415-PNop1-eGFP-scNIC96 scNic96 1-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnic96 ΔSOL scNic96 1-203 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnic96 R2-SOL scNic96 107-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnic96 SOL scNic96 204-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnic96 ΔR2 scNic96 1-108, 166-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnic96 F159A scNic96 1-839, F159A pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnic96 ΔLINKER scNic96 1-60, 107-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnic96 LLLL scNic96 1-839, I46A, 
L49A, V53A, 
L56A 
pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scNIC96 scNic96 1-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnic96 R2-SOL scNic96 107-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnic96 R2 scNic96 1-108, 166-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnic96 F159A scNic96 1-839, F159A pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnic96 ΔLINKER scNic96 1-60, 107-839 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnic96 LLLL scNic96 1-839, I46A, 
L49A, V53A, 
L56A 
pRS415 BamHI, NotI LEU2 this study 
pRS416-PNop1-mCherry-scNIC96 scNic96 1-839 pRS416 BamHI, NotI URA3 this study 
pRS415-PNop1-eGFP-scNUP49 scNup49 1-472 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnup49 E scNup49 1-472, K376E pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnup49 P1 scNup49 1-472, I391P pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnup49 P2 scNup49 1-472, L449P pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnup49 PP scNup49 1-472, I391P, 
L449P 
pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnup49 EPP scNup49 1-472, K376E, 
I391P, L449P 
pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-eGFP-scnup49 EVPIP scNup49 1-472, K376E, 
I390V, I391P, 
V398I, L449P 
pRS415 BamHI, NotI LEU2 this study* 
pRS415-PNop1-mCherry-scNUP49 scNup49 1-472 pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnup49 E scNup49 1-472, K376E pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnup49 P1 scNup49 1-472, I391P pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnup49 P2 scNup49 1-472, L449P pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnup49 PP scNup49 1-472, I391P, 
L449P 
pRS415 BamHI, NotI LEU2 this study 
RS415-PNop1-mCherry-scnup49 EPP scNup49 1-472, K376E, 
I391P, L449P 
pRS415 BamHI, NotI LEU2 this study 
pRS415-PNop1-mCherry-scnup49 EVPIP scNup49 1-472, K376E, 
I390V, I391P, 
V398I, L449P 
pRS415 BamHI, NotI LEU2 this study* 
pRS411-PRPL25-scRPL25-mCherry scRpl25 1-142 pRS411 SacII, BamHI MET15 this study 
pRS413-PRPL25-scRPL25-mCherry scRpl25 1-142 pRS413 SacII, BamHI HIS3 this study 
pFA6a-natNT2 N/A N/A pFA6a N/A N/A (51) 
pRS413 N/A N/A pRS413 N/A HIS3 (52) 
*mutations based on nup49-313 (37) 
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Table S8. 
Yeast strains 
Strain Parental strain Genotype Plasmid Transformed with Analyses Reference 
scnup192Δ BY4741 MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnup192::HIS3 
pRS416-PNop1-
mcherry-
scNUP192 
pRS415-PNop1-
eGFP-scNUP192 
variants 
growth analysis 
poly(A)+ RNA 
export 
this study 
scnup192Δ BY4741 MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnup192::HIS3 
pRS416-PNop1-
mcherry-
scNUP192 
pRS415-PNop1-
eGFP-scNUP192 
variants 
pRS411-PNop1-
scRPL25-mcherry 
scRpl25 
localization 
this study 
scnup192Δ 
scNup57-GFP 
BY4741 
scNup57-GFPa 
MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnup192::natNT2, 
scNUP57-
GFP(S65T)::HIS3MX6 
pRS416-PNop1-
mcherry-
scNUP192 
pRS415-PNop1-
mcherry-scNUP192 
variants 
colocalization of 
scNup192 
variants and 
scNup57 
this study 
scnic96Δ BY4741 MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnic96::HIS3 
pRS416-PNop1-
mcherry-
scNIC96 
pRS415-PNop1-
eGFP-scNIC96 
variants 
growth analysis this study 
scnic96Δ 
scNup57-GFP 
BY4741 
scNup57-GFPa 
MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnic96::natNT2, 
scNUP57-
GFP(S65T)::HIS3MX6 
pRS416-PNop1-
mcherry-
scNIC96 
pRS415-PNop1-
mcherry-scNIC96 
variants 
colocalization of 
scNic96 variants 
and scNup57 
poly(A)+ RNA 
export 
this study 
scnup49Δ BY4741 MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnup49::natNT2 
pRS416-PNop1-
mcherry-
scNUP49 
pRS415-PNop1-
eGFP-scNUP49 
variants 
growth analysis 
poly(A)+ RNA 
assay 
this study 
scnup49Δ BY4741 MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnup49::natNT2 
pRS416-PNop1-
mcherry-
scNUP49 
pRS415-PNop1-
eGFP-scNUP49 
variants 
pRS413-PNop1-
scRPL25-mcherry 
scRpl25 
localization 
this study 
scnup49Δ 
scNup57-GFP 
BY4741 
scNup57-GFPa 
MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
scnup49::natNT2, 
scNUP57-
GFP(S65T)::HIS3MX6 
pRS416-PNop1-
mcherry-
scNUP49 
pRS415-PNop1-
eGFP-scNUP49 
variants 
colocalization of 
scNup192 
variants and 
scNup57 
this study 
a purchased from Invitrogen 
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Table S9. 
Crystallization and cryo protection conditions 
Protein(s) Concentration Crystallization condition Cryo protection condition 
Nup192TAIL 10 mg/ml 50 mM HEPES, pH 7.1 
15 % (w/v) PEG 200 
340 mM sodium chloride 
(optimized by microseeding) 
paratone oil 
Nup188TAIL 10 mg/ml 100 mM HEPES, pH 6.9 
16 % (w/v) PEG 3,350 
200 mM ammonium citrate 
35 % (w/v) PEG 3,350 
hsNup49CCS2+3*•hsNup57CCS3* 
2:2 stoichiometry 
15 mg/ml 100 mM sodium citrate, pH 5.4 
0.5 M sodium chloride 
25 % (v/v) ethylene glycol 
(stepwise, 20 %, 25 %) 
hsNup49CCS2+3*•hsNup57CCS3* 
1:2 stoichiometry 
20 mg/ml 100 mM sodium acetate, pH 3.8 
70 mM calcium chloride 
20 % (v/v) glycerol 
hsNup49CCS2+3* 8 mg/ml 28 % (v/v) dioxane 
10 % (v/v) glycerol 
20 % (v/v) glycerol 
hsNup57CCS3* 16 mg/ml 1.0 M sodium acetate pH 5.3 
1.9 M sodium formate 
paraffin oil 
Nup57CCS3* 
homo-dimer 
16 mg/ml 5 % (w/v) PEG 1,000 
12 % (w/v) PEG 8,000 
paraffin oil 
Nup82NTD•Nup159T•Nup145NAPD 30 mg/ml 100 mM lithium citrate 
20 % (w/v) PEG 3,350 
3 % (v/v) MPD 
20 % (v/v) MPD 
CNT•Nic96R1•sAB-158 25 mg/ml 0.1M TRIS, pH 8.7 
5.7 % (w/v) PEG 20,000 
1 % (v/v) 1-propanol 
25 % (v/v) ethylene glycol 
(stepwise, 2 % steps) 
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 Movie S1. 
Rotating C. thermophilum CNT•Nic96R1 monomer in cartoon representation. CNT•Nic96R1 is 
colored according to Figure 4. sAb-158 is removed for clarity. 
 
Movie S2. 
Rotating C. thermophilum CNT•Nic96R1 monomer in surface representation. CNT•Nic96R1 is 
colored according to Figure 4. sAb-158 is removed for clarity. 
 
Movie S3. 
Rotating Nic96R1 interaction with the three coiled-coil domains of the CNT. The structure is 
colored according to Figure 4. Nic96R1 is shown in surface representation and Nsp1, Nup49, and 
Nup57 are shown in ribbon representation. The Nup49 residues that are mutated in the EPP mutant are 
shown in ball-and-stick representations and colored in magenta. 
 
Movie S4. 
Rotating structure of the C. thermophilum CNT•Nic96R1 asymmetric unit dimer. The two 
CNT•Nic96R1 complexes are colored in blue (CNT) and magenta (Nic96R1) and yellow (CNT) and red 
(Nic96R1), respectively. The two sAB-158 molecules are colored in gray. 
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